Lincoln Pharmaceuticals standalone net profit rises 25.22% in the September 2017 quarter
Sales rise 22.66% to Rs 85.64 crore
Net profit of Lincoln Pharmaceuticals rose 25.22% to Rs 9.93 crore in the quarter ended September 2017 as against Rs 7.93 crore during the previous quarter ended September 2016. Sales rose 22.66% to Rs 85.64 crore in the quarter ended September 2017 as against Rs 69.82 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales85.6469.82 23 OPM %15.1713.56 -PBDT14.8711.46 30 PBT13.5010.60 27 NP9.937.93 25Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 13 2017 | 4:54 PM IST